- Home
- Supplements
- Iron
- Pale Skin
Overview
Verdict
Randomised trials and Cochrane evidence show oral iron reliably raises haemoglobin and ferritin in confirmed deficiency, with pallor resolving as haemoglobin recovers. No benefit when iron stores are normal.
How It Works
Pathways involved
Dosing & Protocol
| Scenario | Dose | Form | Timing |
|---|---|---|---|
| Confirmed iron deficiency | 40-65 mg elemental iron, alternate days | Ferrous sulphate or fumarate | Morning, empty stomach if tolerated |
| Poor tolerance | 25-30 mg elemental iron, alternate days | Ferrous bisglycinate | With a small meal |
| Absorption aid | 100-250 mg vitamin C or a glass of orange juice | Any | With the iron dose |
| Store repletion | Continue 3 months after haemoglobin normalises | Any | Recheck ferritin at 3 months |
- 1
Confirm deficiency first· Before starting
Full blood count and ferritin, with CRP if inflammation is possible. Pallor without iron deficiency needs a different investigation.
- 2
Start alternate-day dosing· Week 1 onward
One morning dose every other day absorbs better and is tolerated better than daily or split dosing.
- 3
Separate from inhibitors· Every dose
No tea, coffee, dairy, calcium supplements or antacids within two hours of the dose.
- 4
Recheck at 4 weeks· Week 4
Haemoglobin should be rising. If it is not, absorption, adherence or the diagnosis needs review.
- 5
Keep going for stores· Months 1-6
Continue about three months after haemoglobin normalises to refill ferritin, then stop and recheck.
Evidence
- Best available evidence
- Randomised absorption trials and a Cochrane systematic review
- Typical effect
- Haemoglobin rise within 2-4 weeks; visible colour over 4-8 weeks; stores over 3-6 months
- Studied dose
- 40-100 mg elemental iron, alternate days
- Time to effect
- 2-4 weeks for haemoglobin
- Certainty of evidence
- High in confirmed deficiency; not applicable when ferritin is normal
Randomised and crossover absorption trials comparing consecutive-day with alternate-day oral iron, a randomised trial of vitamin C added to iron, and a Cochrane review of intermittent supplementation in menstruating women.
Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
Fernandez-Gaxiola AC, et al.
Intermittent iron supplementation may reduce anaemia and may improve iron stores among menstruating women in populations with different anaemia and malaria backgrounds. In comparison with daily supplementation, the provision of iron supplements intermittently is probably as effective in preventing or controlling anaemia.
The efficacy and safety of vitamin C for iron supplementation in adult patients with iron deficiency anemia: a randomized clinical trial
Li N, Zhao G, Wu W
Among patients with IDA, oral iron supplements alone were equivalent to oral iron supplements plus vitamin C in improving hemoglobin recovery and iron absorption.
Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women
Stoffel NU, et al.
Alternate day dosing of oral iron supplements in anemic women may be preferable because it sharply increases FIA.
Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women
Stoffel NU, Cercamondi CI, Brittenham G +5 more
Alternate-day single doses produced greater total fractional iron absorption than daily or twice-daily dosing.
Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study
von Siebenthal HK, et al.
At equal total iron doses, compared to consecutive day dosing of iron, alternate day dosing did not result in higher serum ferritin but reduced iron deficiency at 6 months and triggered fewer gastrointestinal side effects.
Safety
Pallor needs a cause, not just iron
Pallor with weight loss, blood in stool, heavy periods or breathlessness needs medical assessment. Iron deficiency in an adult male or a postmenopausal woman is a bleeding investigation until proven otherwise.
Interactions & Conflicts
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| Proton pump inhibitors and antacids | moderate | Reduced gastric acid impairs iron solubility and absorption | Take iron with vitamin C, separated from antacids; discuss ongoing PPI use |
| Calcium supplements and dairy | moderate | Direct competition for absorption | Separate by at least 2 hours |
| Levothyroxine | moderate | Iron binds thyroxine and reduces its absorption | Separate by at least 4 hours |
| Tetracycline and quinolone antibiotics | moderate | Chelation reduces absorption of both drug and iron | Separate by at least 2-4 hours |
| Tea, coffee and high-phytate foods | low | Polyphenols and phytates bind non-haem iron | Avoid within an hour either side of the dose |
| Haemochromatosis or repeated transfusion | high | Iron loading causes organ damage | Do not supplement without specialist advice |
References
- Stoffel NU et al. Iron absorption from oral iron supplements given on consecutive versus alternate days. Lancet Haematol. 2017
- Stoffel NU et al. Iron absorption from supplements is greater with alternate day dosing in iron-deficient anemic women. Haematologica. 2020
- Fernandez-Gaxiola AC, De-Regil LM. Intermittent iron supplementation for reducing anaemia in menstruating women. Cochrane Database Syst Rev. 2019
Frequently Asked Questions
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.